Aspirin may not lower risk for first CV event in those with family history of premature MI

In people with a family history of parental premature MI, aspirin for primary prevention was not associated with reduced CV events or overall mortality, according to data published in the European Journal of Preventive Cardiology.
“The family history of premature CVD is a major risk enhancer for the occurrence of CV events,” Daniel Caldeira, MD, PhD, professor at the Cardiovascular Center of the University of Lisbon, Portugal, and colleagues wrote. “While family history of CVD is conceptually simple, it results from a complex interplay between environment and genetics, as

In people with a family history of parental premature MI, aspirin for primary prevention was not associated with reduced CV events or overall mortality, according to data published in the European Journal of Preventive Cardiology.
“The family history of premature CVD is a major risk enhancer for the occurrence of CV events,” Daniel Caldeira, MD, PhD, professor at the Cardiovascular Center of the University of Lisbon, Portugal, and colleagues wrote. “While family history of CVD is conceptually simple, it results from a complex interplay between environment and genetics, as